The ImmunoGenes Difference

FcRn Overexpression Leads to Better Antigen Presentation and Greater Antibody Diversity

LEARN MORE

What Our Customers Are Saying

"We recently approached ImmunoGenes and they were able to deliver monoclonal antibodies specific to CB-1, which upon characterization yielded the first monoclonal antibody displaying formidable characteristics and fulfilling our extensive expectations. This antibody displays superior specificity and binding characteristics, making it an irreplaceable tool in our CB-1 development programs."
- István Katona, Head of Department, Institute of Experimental Medicine of the Hungarian Academy of Sciences
-

Enter Our Contest

Patented Technology

Enter the ImmunoGenes contest and win a monoclonal antibody development project against a difficult target at a special price.

Learn More

Customized Solutions

Patented Technology

Our patented technology allows us to produce high quality and diverse antibodies against extremely challenging antigens.

Learn More

 

Research Articles

Patented Technology

ImmunoGenes is the leader in developing transgenic concepts based on published research by experienced scientists.

Learn More